Monkeypox vaccine strategy shift yields more supply for some, hurdles for others
Most places in the United States with heavy monkeypox caseloads have shifted their vaccination strategies to the Biden administration's low-dose, intradermal approach -- and they are reporting varying results so far. Some say the shift has stretched their vaccine supply, helping them meet a growing demand for the Jynneos monkeypox vaccine....